Sato T, Selleri C, Anderson S, Young N S, Maciejewski J P
Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, U.S.A.
Br J Haematol. 1997 May;97(2):356-65. doi: 10.1046/j.1365-2141.1997.562704.x.
Interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and Fas-ligand can mediate potent inhibitory signals in haemopoietic cells. Clinical and laboratory studies have suggested the involvement of these cytokines in the regulation of normal haemopoiesis and in the pathophysiology of bone marrow (BM) failure syndromes. As the effects of cytokines may also be regulated at the cellular receptor level, we studied the expression and modulation of TNF receptor (TNFR), IFN-gammaR and Fas-R on haemopoietic progenitor cells. In freshly isolated BM, using flow cytometry, TNFR1 (p55), TNFR2 (p75), IFN-gammaR, and Fas-R were detected on 5-12% of mononuclear cells. Two-colour staining showed comparable receptor expression on a CD34+ population, which includes haemopoietic progenitor and stem cells. Using reverse transcriptase-PCR (RT-PCR) transcription of mRNA coding for these receptors was demonstrated in fresh, highly purified CD34+ cells. These findings indicate that the effects of these factors on progenitor cells may be directly mediated. In cultured BM cells, expression of TNFR1 was not influenced by IFN-gamma, TNF-alpha or apoptosis-inducing anti-Fas monoclonal antibody (mAb). IFN-gamma decreased CD34+ cell TNFR2 expression. CD34+ cell Fas-R expression was increased by IFN-gamma and TNF-alpha. IFN-gammaR expression was enhanced by anti-Fas mAb and to lesser degree with TNF-alpha. Similar results were obtained with RT-PCR analysis in cultured CD34+ cells. Potentiation of anti-Fas mAb-mediated inhibition of haemopoietic colony formation by IFN-gamma and TNF-alpha was observed. Similarly, anti-Fas mAb enhanced the inhibitory effects of IFN-gamma. These results suggest that, in addition to interacting at the level of intracellular signalling pathways, IFN-gamma, TNF-alpha or Fas-ligand may potentiate or antagonize their effects through modulation of cytokine receptor expression.
干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)和Fas配体可在造血细胞中介导强大的抑制信号。临床和实验室研究表明,这些细胞因子参与正常造血的调节以及骨髓(BM)衰竭综合征的病理生理学过程。由于细胞因子的作用也可能在细胞受体水平受到调节,我们研究了造血祖细胞上肿瘤坏死因子受体(TNFR)、IFN-γ受体和Fas受体的表达及调节情况。在新鲜分离的骨髓中,通过流式细胞术检测到5%-12%的单核细胞上存在TNFR1(p55)、TNFR2(p75)、IFN-γ受体和Fas受体。双色染色显示在包括造血祖细胞和干细胞的CD34+群体上有类似的受体表达。使用逆转录聚合酶链反应(RT-PCR)在新鲜、高度纯化的CD34+细胞中证实了编码这些受体的mRNA的转录。这些发现表明这些因子对祖细胞的作用可能是直接介导的。在培养的骨髓细胞中,TNFR1的表达不受IFN-γ、TNF-α或诱导凋亡的抗Fas单克隆抗体(mAb)的影响。IFN-γ降低了CD34+细胞TNFR2的表达。IFN-γ和TNF-α增加了CD34+细胞Fas受体的表达。抗Fas mAb增强了IFN-γ受体的表达,TNF-α的增强作用较小。在培养的CD34+细胞中进行RT-PCR分析也得到了类似的结果。观察到IFN-γ和TNF-α增强了抗Fas mAb介导的对造血集落形成的抑制作用。同样,抗Fas mAb增强了IFN-γ的抑制作用。这些结果表明,除了在细胞内信号通路水平相互作用外,IFN-γ、TNF-α或Fas配体可能通过调节细胞因子受体的表达来增强或拮抗它们的作用。